Hello everyone, Happy New Year! Being on the downslope of a recent peak in infection rates brings hope to those of us on the front lines of battling the pandemic. I have hope that we soon will be able to attain a sense of “normal”.
As we enter the new year, there are so many exciting events and happenings going on for the National Lipid Association, beginning with this edition of LipidSpin. I am proud to present you the MWLA/PLA edition of LipidSpin. Consistent with the theme “New approaches for Managing Atherogenic Particles”, this edition covers exciting topics, ranging from hypertriglyceridemia management to physician and patient access for the newly FDA-approved LDL-lowering therapy, Inclisiran.
I hope that reading this edition complements your attendance of the spring Clinical Lipid Update (CLU) in San Diego, California. Beyond this spring CLU, be sure to be sure to look for updates on the annual Scientific Sessions in June. I am confident that the educational programming will be spectacular, and that the venue in Scottsdale will not disappoint. To get you further energized, I invite you to read the findings from the NLA hosted Global Think Tank on Lipoprotein(a). It is now published online in the journal Progress in Cardiovascular Diseases. Also, be on the lookout for the DEI 21-day challenge that is quickly approaching. I hope that everyone can engage with this important event.
As I near the end of my presidency, I feel so fortunate to have had this experience. I had the opportunity to participate in many different NLA events and initiatives. I loved that we started a new DEI Task Force, successfully conducted both live and virtual educational events, published new scientific statements with more coming in the very near future. As always, the NLA staff have been outstanding with their commitment to excellence and superb support. I’d like to thank Drs. Kaye-Eileen Willard and Lynne Braun for their fierce dedication to LipidSpin. They have graced our membership with riveting and informative material to help us better treat our patients and the NLA is indebted to their service.